位置:首页 > 蛋白库 > MAGAB_HUMAN
MAGAB_HUMAN
ID   MAGAB_HUMAN             Reviewed;         429 AA.
AC   P43364; Q5ETU4; Q6ZRZ5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=Melanoma-associated antigen 11;
DE   AltName: Full=Cancer/testis antigen 1.11;
DE            Short=CT1.11;
DE   AltName: Full=MAGE-11 antigen;
GN   Name=MAGEA11 {ECO:0000303|PubMed:28397838, ECO:0000312|HGNC:HGNC:6798};
GN   Synonyms=MAGE11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7927540; DOI=10.1007/bf01246677;
RA   De Plaen E., Arden K., Traversari C., Gaforio J.J., Szikora J.-P.,
RA   De Smet C., Brasseur F., van der Bruggen P., Lethe B.G., Lurquin C.,
RA   Brasseur R., Chomez P., de Backer O., Cavenee W., Boon T.;
RT   "Structure, chromosomal localization, and expression of 12 genes of the
RT   MAGE family.";
RL   Immunogenetics 40:360-369(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Testis;
RX   PubMed=15684378; DOI=10.1128/mcb.25.4.1238-1257.2005;
RA   Bai S., He B., Wilson E.M.;
RT   "Melanoma antigen gene protein MAGE-11 regulates androgen receptor function
RT   by modulating the interdomain interaction.";
RL   Mol. Cell. Biol. 25:1238-1257(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT PRO-57.
RX   PubMed=28397838; DOI=10.1038/mp.2017.60;
RA   Harripaul R., Vasli N., Mikhailov A., Rafiq M.A., Mittal K.,
RA   Windpassinger C., Sheikh T.I., Noor A., Mahmood H., Downey S., Johnson M.,
RA   Vleuten K., Bell L., Ilyas M., Khan F.S., Khan V., Moradi M., Ayaz M.,
RA   Naeem F., Heidari A., Ahmed I., Ghadami S., Agha Z., Zeinali S., Qamar R.,
RA   Mozhdehipanah H., John P., Mir A., Ansar M., French L., Ayub M.,
RA   Vincent J.B.;
RT   "Mapping autosomal recessive intellectual disability: combined microarray
RT   and exome sequencing identifies 26 novel candidate genes in 192
RT   consanguineous families.";
RL   Mol. Psychiatry 23:973-984(2018).
CC   -!- FUNCTION: Acts as androgen receptor coregulator that increases androgen
CC       receptor activity by modulating the receptors interdomain interaction.
CC       May play a role in embryonal development and tumor transformation or
CC       aspects of tumor progression. {ECO:0000269|PubMed:15684378}.
CC   -!- INTERACTION:
CC       P43364; Q68CK6: ACSM2B; NbExp=3; IntAct=EBI-739552, EBI-2880280;
CC       P43364; O95696: BRD1; NbExp=3; IntAct=EBI-739552, EBI-714754;
CC       P43364; Q6P5X5: C22orf39; NbExp=3; IntAct=EBI-739552, EBI-7317823;
CC       P43364; P55210: CASP7; NbExp=3; IntAct=EBI-739552, EBI-523958;
CC       P43364; Q969G5: CAVIN3; NbExp=3; IntAct=EBI-739552, EBI-3893101;
CC       P43364; Q8IYK2: CCDC105; NbExp=3; IntAct=EBI-739552, EBI-10818513;
CC       P43364; Q9BWC9: CCDC106; NbExp=3; IntAct=EBI-739552, EBI-711501;
CC       P43364; Q49A88-3: CCDC14; NbExp=3; IntAct=EBI-739552, EBI-12105646;
CC       P43364; Q8IYE0: CCDC146; NbExp=3; IntAct=EBI-739552, EBI-10749669;
CC       P43364; Q2M243: CCDC27; NbExp=3; IntAct=EBI-739552, EBI-12314269;
CC       P43364; P42772: CDKN2B; NbExp=4; IntAct=EBI-739552, EBI-711280;
CC       P43364; Q96AJ1: CLUAP1; NbExp=5; IntAct=EBI-739552, EBI-739780;
CC       P43364; P31146: CORO1A; NbExp=3; IntAct=EBI-739552, EBI-1046676;
CC       P43364; Q8WZ74: CTTNBP2; NbExp=3; IntAct=EBI-739552, EBI-1774260;
CC       P43364; Q6IS01: DLGAP1; NbExp=3; IntAct=EBI-739552, EBI-11961832;
CC       P43364; Q96BY6: DOCK10; NbExp=3; IntAct=EBI-739552, EBI-748520;
CC       P43364; Q3B820: FAM161A; NbExp=3; IntAct=EBI-739552, EBI-719941;
CC       P43364; Q8TAE8: GADD45GIP1; NbExp=3; IntAct=EBI-739552, EBI-372506;
CC       P43364; P23434: GCSH; NbExp=3; IntAct=EBI-739552, EBI-715444;
CC       P43364; P09067: HOXB5; NbExp=3; IntAct=EBI-739552, EBI-3893317;
CC       P43364; Q8TCB0: IFI44; NbExp=3; IntAct=EBI-739552, EBI-2831730;
CC       P43364; P20809: IL11; NbExp=4; IntAct=EBI-739552, EBI-751694;
CC       P43364; P40189: IL6ST; NbExp=3; IntAct=EBI-739552, EBI-1030834;
CC       P43364; Q92613: JADE3; NbExp=4; IntAct=EBI-739552, EBI-10278909;
CC       P43364; Q8IYD9: LAS2; NbExp=4; IntAct=EBI-739552, EBI-749878;
CC       P43364; A0A0S2Z5F8: LMBR1L; NbExp=3; IntAct=EBI-739552, EBI-16434477;
CC       P43364; P58340: MLF1; NbExp=5; IntAct=EBI-739552, EBI-721328;
CC       P43364; Q9Y6M9: NDUFB9; NbExp=4; IntAct=EBI-739552, EBI-713654;
CC       P43364; O94818-2: NOL4; NbExp=3; IntAct=EBI-739552, EBI-10190763;
CC       P43364; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-739552, EBI-741158;
CC       P43364; Q9H0N5: PCBD2; NbExp=3; IntAct=EBI-739552, EBI-634289;
CC       P43364; O14832: PHYH; NbExp=4; IntAct=EBI-739552, EBI-721853;
CC       P43364; Q96FE7: PIK3IP1; NbExp=3; IntAct=EBI-739552, EBI-10285708;
CC       P43364; Q9Y237-2: PIN4; NbExp=3; IntAct=EBI-739552, EBI-11749201;
CC       P43364; Q63HM9: PLCXD3; NbExp=3; IntAct=EBI-739552, EBI-12105500;
CC       P43364; P30405: PPIF; NbExp=3; IntAct=EBI-739552, EBI-5544229;
CC       P43364; Q8N3J5: PPM1K; NbExp=3; IntAct=EBI-739552, EBI-3923368;
CC       P43364; Q6VN20: RANBP10; NbExp=3; IntAct=EBI-739552, EBI-310569;
CC       P43364; Q96EN9: REX1BD; NbExp=3; IntAct=EBI-739552, EBI-745810;
CC       P43364; Q9H788: SH2D4A; NbExp=2; IntAct=EBI-739552, EBI-747035;
CC       P43364; Q7Z614-3: SNX20; NbExp=3; IntAct=EBI-739552, EBI-12336127;
CC       P43364; P49675: STAR; NbExp=6; IntAct=EBI-739552, EBI-722932;
CC       P43364; Q9P2R7: SUCLA2; NbExp=3; IntAct=EBI-739552, EBI-2269898;
CC       P43364; P51687: SUOX; NbExp=3; IntAct=EBI-739552, EBI-3921347;
CC       P43364; Q15560: TCEA2; NbExp=5; IntAct=EBI-739552, EBI-710310;
CC       P43364; Q9BQ70: TCF25; NbExp=5; IntAct=EBI-739552, EBI-745182;
CC       P43364; Q8N131: TMEM123; NbExp=4; IntAct=EBI-739552, EBI-749248;
CC       P43364; Q9NXH9: TRMT1; NbExp=5; IntAct=EBI-739552, EBI-748900;
CC       P43364; Q7Z6J8: UBE3D; NbExp=3; IntAct=EBI-739552, EBI-9379147;
CC       P43364; Q15007: WTAP; NbExp=4; IntAct=EBI-739552, EBI-751647;
CC       P43364-2; Q8TDX5: ACMSD; NbExp=3; IntAct=EBI-10178634, EBI-749859;
CC       P43364-2; I7GY12: B9838V1; NbExp=3; IntAct=EBI-10178634, EBI-10178638;
CC       P43364-2; O43521: BCL2L11; NbExp=3; IntAct=EBI-10178634, EBI-526406;
CC       P43364-2; Q9BXY8: BEX2; NbExp=3; IntAct=EBI-10178634, EBI-745073;
CC       P43364-2; Q49A88: CCDC14; NbExp=3; IntAct=EBI-10178634, EBI-751035;
CC       P43364-2; Q8IYE0-2: CCDC146; NbExp=3; IntAct=EBI-10178634, EBI-10247802;
CC       P43364-2; Q86Y33: CDC20B; NbExp=3; IntAct=EBI-10178634, EBI-10260504;
CC       P43364-2; Q96AJ1: CLUAP1; NbExp=3; IntAct=EBI-10178634, EBI-739780;
CC       P43364-2; P68400: CSNK2A1; NbExp=3; IntAct=EBI-10178634, EBI-347804;
CC       P43364-2; Q8IXB1-2: DNAJC10; NbExp=3; IntAct=EBI-10178634, EBI-10262451;
CC       P43364-2; Q96BY6-3: DOCK10; NbExp=3; IntAct=EBI-10178634, EBI-10282566;
CC       P43364-2; Q16206-2: ENOX2; NbExp=3; IntAct=EBI-10178634, EBI-10179508;
CC       P43364-2; P46926: GNPDA1; NbExp=3; IntAct=EBI-10178634, EBI-749356;
CC       P43364-2; P09067: HOXB5; NbExp=3; IntAct=EBI-10178634, EBI-3893317;
CC       P43364-2; P20809: IL11; NbExp=3; IntAct=EBI-10178634, EBI-751694;
CC       P43364-2; Q17RA0: IL6ST; NbExp=3; IntAct=EBI-10178634, EBI-10238517;
CC       P43364-2; Q92613: JADE3; NbExp=3; IntAct=EBI-10178634, EBI-10278909;
CC       P43364-2; Q13330: MTA1; NbExp=3; IntAct=EBI-10178634, EBI-714236;
CC       P43364-2; Q9Y6M9: NDUFB9; NbExp=3; IntAct=EBI-10178634, EBI-713654;
CC       P43364-2; P29474: NOS3; NbExp=3; IntAct=EBI-10178634, EBI-1391623;
CC       P43364-2; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-10178634, EBI-741158;
CC       P43364-2; Q9H0N5: PCBD2; NbExp=3; IntAct=EBI-10178634, EBI-634289;
CC       P43364-2; Q9Y237: PIN4; NbExp=3; IntAct=EBI-10178634, EBI-714599;
CC       P43364-2; Q8N490: PNKD; NbExp=3; IntAct=EBI-10178634, EBI-746368;
CC       P43364-2; Q96JH8: RADIL; NbExp=3; IntAct=EBI-10178634, EBI-744267;
CC       P43364-2; Q86U06: RBM23; NbExp=3; IntAct=EBI-10178634, EBI-780319;
CC       P43364-2; Q86U06-2: RBM23; NbExp=3; IntAct=EBI-10178634, EBI-10258579;
CC       P43364-2; Q7Z614: SNX20; NbExp=3; IntAct=EBI-10178634, EBI-744896;
CC       P43364-2; P49675: STAR; NbExp=3; IntAct=EBI-10178634, EBI-722932;
CC       P43364-2; Q9BQ70: TCF25; NbExp=3; IntAct=EBI-10178634, EBI-745182;
CC       P43364-2; Q8N1Q8: THEM5; NbExp=3; IntAct=EBI-10178634, EBI-10264970;
CC       P43364-2; Q8N131: TMEM123; NbExp=3; IntAct=EBI-10178634, EBI-749248;
CC       P43364-2; Q5VU62: TPM3; NbExp=3; IntAct=EBI-10178634, EBI-10184033;
CC       P43364-2; Q9NXH9: TRMT1; NbExp=3; IntAct=EBI-10178634, EBI-748900;
CC       P43364-2; Q99757: TXN2; NbExp=3; IntAct=EBI-10178634, EBI-2932492;
CC       P43364-2; Q9Y2K6: USP20; NbExp=3; IntAct=EBI-10178634, EBI-2511991;
CC       P43364-2; Q68CQ4: UTP25; NbExp=3; IntAct=EBI-10178634, EBI-747711;
CC       P43364-2; Q6PEW1: ZCCHC12; NbExp=3; IntAct=EBI-10178634, EBI-748373;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15684378}. Cytoplasm
CC       {ECO:0000269|PubMed:15684378}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P43364-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P43364-2; Sequence=VSP_018576;
CC   -!- TISSUE SPECIFICITY: Expressed in tumors of several types, such as
CC       melanoma, head and neck squamous cell carcinoma, lung carcinoma and
CC       breast carcinoma. Expressed in testis, ovary, prostate, cancerous
CC       prostate, breast and adrenal tissue. {ECO:0000269|PubMed:15684378}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA68870.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10686; AAA68870.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AY747607; AAW71787.1; -; mRNA.
DR   EMBL; AK127849; BAC87161.1; -; mRNA.
DR   EMBL; BC004479; AAH04479.2; -; mRNA.
DR   CCDS; CCDS48180.1; -. [P43364-1]
DR   PIR; I38660; I38660.
DR   RefSeq; NP_001011544.1; NM_001011544.1.
DR   RefSeq; NP_005357.2; NM_005366.4. [P43364-1]
DR   RefSeq; XP_016885010.1; XM_017029521.1.
DR   RefSeq; XP_016885011.1; XM_017029522.1. [P43364-2]
DR   PDB; 6WJH; X-ray; 2.19 A; A/B/C/D=218-429.
DR   PDBsum; 6WJH; -.
DR   AlphaFoldDB; P43364; -.
DR   SMR; P43364; -.
DR   BioGRID; 110284; 146.
DR   IntAct; P43364; 115.
DR   MINT; P43364; -.
DR   STRING; 9606.ENSP00000347358; -.
DR   MoonDB; P43364; Predicted.
DR   iPTMnet; P43364; -.
DR   PhosphoSitePlus; P43364; -.
DR   BioMuta; MAGEA11; -.
DR   DMDM; 97536722; -.
DR   MassIVE; P43364; -.
DR   MaxQB; P43364; -.
DR   PaxDb; P43364; -.
DR   PeptideAtlas; P43364; -.
DR   PRIDE; P43364; -.
DR   ProteomicsDB; 55626; -. [P43364-1]
DR   ProteomicsDB; 55627; -. [P43364-2]
DR   TopDownProteomics; P43364-1; -. [P43364-1]
DR   Antibodypedia; 30628; 234 antibodies from 30 providers.
DR   DNASU; 4110; -.
DR   Ensembl; ENST00000355220.6; ENSP00000347358.5; ENSG00000185247.15. [P43364-1]
DR   GeneID; 4110; -.
DR   KEGG; hsa:4110; -.
DR   MANE-Select; ENST00000355220.6; ENSP00000347358.5; NM_005366.5; NP_005357.2.
DR   UCSC; uc004fdq.4; human. [P43364-1]
DR   CTD; 4110; -.
DR   DisGeNET; 4110; -.
DR   GeneCards; MAGEA11; -.
DR   HGNC; HGNC:6798; MAGEA11.
DR   HPA; ENSG00000185247; Tissue enriched (epididymis).
DR   MIM; 300344; gene.
DR   neXtProt; NX_P43364; -.
DR   OpenTargets; ENSG00000185247; -.
DR   PharmGKB; PA30544; -.
DR   VEuPathDB; HostDB:ENSG00000185247; -.
DR   eggNOG; KOG4562; Eukaryota.
DR   GeneTree; ENSGT00940000164167; -.
DR   InParanoid; P43364; -.
DR   OMA; KNYEEYF; -.
DR   OrthoDB; 1195799at2759; -.
DR   PhylomeDB; P43364; -.
DR   TreeFam; TF328505; -.
DR   PathwayCommons; P43364; -.
DR   SignaLink; P43364; -.
DR   SIGNOR; P43364; -.
DR   BioGRID-ORCS; 4110; 12 hits in 693 CRISPR screens.
DR   GeneWiki; MAGEA11; -.
DR   GenomeRNAi; 4110; -.
DR   Pharos; P43364; Tbio.
DR   PRO; PR:P43364; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P43364; protein.
DR   Bgee; ENSG00000185247; Expressed in corpus epididymis and 28 other tissues.
DR   ExpressionAtlas; P43364; baseline and differential.
DR   Genevisible; P43364; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0042826; F:histone deacetylase binding; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 1.10.10.1200; -; 1.
DR   Gene3D; 1.10.10.1210; -; 1.
DR   InterPro; IPR037445; MAGE.
DR   InterPro; IPR021072; MAGE_N.
DR   InterPro; IPR041898; MAGE_WH1.
DR   InterPro; IPR041899; MAGE_WH2.
DR   InterPro; IPR030099; MAGEA11.
DR   InterPro; IPR002190; MHD_dom.
DR   PANTHER; PTHR11736; PTHR11736; 1.
DR   PANTHER; PTHR11736:SF146; PTHR11736:SF146; 1.
DR   Pfam; PF01454; MAGE; 1.
DR   Pfam; PF12440; MAGE_N; 1.
DR   SMART; SM01373; MAGE; 1.
DR   SMART; SM01392; MAGE_N; 1.
DR   PROSITE; PS50838; MAGE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Nucleus; Reference proteome;
KW   Tumor antigen.
FT   CHAIN           1..429
FT                   /note="Melanoma-associated antigen 11"
FT                   /id="PRO_0000156710"
FT   DOMAIN          222..421
FT                   /note="MAGE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00127"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          188..215
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        193..214
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..35
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_018576"
FT   VARIANT         57
FT                   /note="S -> P (found in a family with intellectual
FT                   disability; unknown pathological significance;
FT                   dbSNP:rs1557362265)"
FT                   /evidence="ECO:0000269|PubMed:28397838"
FT                   /id="VAR_080775"
FT   VARIANT         191
FT                   /note="S -> R (in dbSNP:rs2233049)"
FT                   /id="VAR_053497"
FT   HELIX           221..238
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           245..251
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           254..259
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           260..275
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   STRAND          277..283
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   TURN            284..287
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   STRAND          288..293
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           294..296
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           312..324
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           331..338
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           339..341
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   TURN            350..352
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           355..360
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           362..365
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   STRAND          368..373
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   STRAND          382..386
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           388..393
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           396..406
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           411..413
FT                   /evidence="ECO:0007829|PDB:6WJH"
FT   HELIX           415..422
FT                   /evidence="ECO:0007829|PDB:6WJH"
SQ   SEQUENCE   429 AA;  48129 MW;  FB399ABF47B4C49B CRC64;
     METQFRRGGL GCSPASIKRK KKREDSGDFG LQVSTMFSED DFQSTERAPY GPQLQWSQDL
     PRVQVFREQA NLEDRSPRRT QRITGGEQVL WGPITQIFPT VRPADLTRVI MPLEQRSQHC
     KPEEGLQAQE EDLGLVGAQA LQAEEQEAAF FSSTLNVGTL EELPAAESPS PPQSPQEESF
     SPTAMDAIFG SLSDEGSGSQ EKEGPSTSPD LIDPESFSQD ILHDKIIDLV HLLLRKYRVK
     GLITKAEMLG SVIKNYEDYF PEIFREASVC MQLLFGIDVK EVDPTSHSYV LVTSLNLSYD
     GIQCNEQSMP KSGLLIIVLG VIFMEGNCIP EEVMWEVLSI MGVYAGREHF LFGEPKRLLT
     QNWVQEKYLV YRQVPGTDPA CYEFLWGPRA HAETSKMKVL EYIANANGRD PTSYPSLYED
     ALREEGEGV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024